Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 7OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 4Gastrointestinal 3Genitourinary 2Dermatologic 2Classical hematology 2Thoracic 1Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 4399Urinary Bladder Neoplasms 1078Carcinoma, Renal Cell 1041Kidney Neoplasms 567Breast Neoplasms 453Neoplasms 403Carcinoma, Transitional Cell 299Neoplasm Metastasis 250Lung Neoplasms 242Testicular Neoplasms 202Melanoma 195Colorectal Neoplasms 193Ovarian Neoplasms 163Carcinoma, Non-Small-Cell Lung 150Sarcoma 135Non-Muscle Invasive Bladder Neoplasms 135Pancreatic Neoplasms 124Colonic Neoplasms 121Head and Neck Neoplasms 116Uterine Cervical Neoplasms 115Wilms Tumor 108Recurrence 106Motor Activity 100Stomach Neoplasms 89Urologic Neoplasms 88Neuroblastoma 88Disease 85Multiple Myeloma 83Carcinoma, Hepatocellular 79Adenocarcinoma 79

Interventions

tretazicar 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Adenoviridae Infections × Genitourinary × Clear all
NCT02555397 2024-10-10

Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer

Henry Ford Health System

Phase 1 Completed
15 enrolled 11 charts
Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

NCT04374240 2021-11-03

AdUP

University of Birmingham

Phase 1 Completed
18 enrolled
Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡